New Vernon Capital Holdings II’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,360
Closed -$265K 20
2018
Q4
$265K Hold
1,360
0.41% 30
2018
Q3
$282K Buy
1,360
+120
+10% +$23.6K 0.29% 33
2018
Q2
$229K Buy
+1,240
New +$219K 0.25% 36

Other funds holding AMGN

New Vernon Capital Holdings II's AMGN Position: Q1 2019 in Review

New Vernon Capital Holdings II sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,360 shares — an estimated $265K sold.

New Vernon Capital Holdings II first reported a position in AMGN in Q2 2018 and held it in 3 quarters. The position peaked at $282K in Q3 2018. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • New Vernon Capital Holdings II reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • New Vernon Capital Holdings II sold 1,360 Amgen shares in Q1 2019, an estimated $265K.
  • New Vernon Capital Holdings II first reported a position in Amgen in Q2 2018 and held it in 3 quarters.
  • New Vernon Capital Holdings II's Amgen position peaked at $282K in Q3 2018.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on New Vernon Capital Holdings II's 13F filing for Q1 2019, filed 13 May 2019.